Roxadustat is a hypoxia-inducible factor prolyl hydroxylase inhibitor belonging to the anti-anemia drug class, primarily used for treating anemia associated with chronic kidney disease in patients undergoing… Read more






Roxadustat is a hypoxia-inducible factor prolyl hydroxylase inhibitor belonging to the anti-anemia drug class, primarily used for treating anemia associated with chronic kidney disease in patients undergoing dialysis. To ensure safety and efficacy during pharmaceutical development, laboratories rely on high-quality reference standards of the parent drug and its related compounds. This collection provides essential materials for rigorous analytical testing, including impurity profiling to monitor process-related substances such as desmethyl and chloro variants. Furthermore, the range includes critical metabolites like O-glucuronide, alongside stable isotope labelled compounds, which serve as internal standards for accurate quantification in mass spectrometry-based assays. By utilizing these specialized reference materials, analysts can perform comprehensive method validation and routine quality control, ensuring strict compliance with regulatory standards throughout the drug’s lifecycle.